According to IMARC Group’s latest report, titled “Tissue Engineering Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027.’the global tissue engineering market reached a value of US$ 13.84 Billion in 2021.Tissue engineering refers to a process of developing biological substitutes that aid in replacing, maintaining, restoring and improving damaged tissues and organs in the body. It involves combining cells, active molecules and scaffolds into functional tissues. Tissue engineering also acts as an effective alternative to surgical reconstructive procedures, mechanical devices and transplants. As a result, it finds extensive application in dentistry, orthopedics, neurology, cardiovascular, skin and musculoskeletal branches of medical sciences.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request for a PDF sample of this report: https://www.imarcgroup.com/tissue-engineering-market/requestsample

The global tissue engineering market is primarily being driven by the increasing prevalence of obesity, cancer, diabetes and cardiovascular disorders among the masses. In line with this, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. Moreover, various technological advancements, such as the launch of organ-on-a-chip solutions and three-dimensional (3D) bioprinters, are favoring the market growth. Other factors, including the implementation of favorable government policies for improving healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biotechnology, are creating a positive outlook for the market. Looking forward, IMARC Group expects the market to reach US$ 29.91 Billion by 2027, exhibiting at a CAGR of 13.10% during 2022-2027.

Competitive Landscape:

• AbbVie Inc.
• Braun Melsungen AG
• Baxter International Inc
• Becton
• Dickinson and Company
• Integra LifeSciences Corporation
• Organogenesis Holdings Inc
• RTI Surgical
• Smith & Nephew plc
• Stryker Corporation
• Vericel Corporation
• Zimmer Biomet.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global tissue engineering market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, application and end user.

Breakup by Type:

• Synthetic Scaffold Material
• Biologically Derived Scaffold Material
• Others

Breakup by Application:

• Orthopedics and Musculoskeletal
• Neurology
• Cardiovascular
• Skin and Integumentary
• Dental
• Others

Breakup by End User:

• Hospitals and Clinics
• Ambulatory Facilities

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures:  https://bit.ly/37bMk1K

We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key highlights of the report:                                                           

• Market Performance (2015-2020)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• The Impact of COVID-19 on the Global Market
• Value Chain Analysis
• Structure of the Global Market
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us                                                                      

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: [email protected]

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800